Company news
Arovella Therapeutics Limited news in 2018
Arovella Therapeutics Limited's news releases, calls and decks from 2018, newest first.
SUDA Signs Agreement With Mitsubishi Tanabe
December 18, 2018
ZLD to Invest in Development of Oral Spray Formulations
December 5, 2018
SUDA Enters Agreement To Develop Cannabinoid Spray
December 5, 2018
SUDA Receives R&D Tax Incentive Refund
November 14, 2018
ZolpiMist Market Update
November 12, 2018
SUDA Signs Agreement For SUD-001H For US Market
November 7, 2018
Appendix 4C, Market Update and Top 20
October 28, 2018
Request for Trading Halt
September 11, 2018
SUDA Achieves TGA GMP Licence
August 20, 2018
Business Development Update
July 15, 2018
Anagrelide Update
July 11, 2018
Prospectus for a Renounceable Pro Rata Offer
July 1, 2018
Settlement with HC Berlin Pharma and Rights Issue
July 1, 2018
Shareholder Update
June 20, 2018
SUDA Expands Patent Coverage For Sildenafil
June 17, 2018
SUDA announces update on ZolpiMist in USA and Canada
June 15, 2018
SUDA expands dialogue with World Health Organisation
May 7, 2018
HC Berlin Pharma Update
May 1, 2018
SUDA Completes Divestment of Subsidiary
March 7, 2018
Divestment Of Non-Core Subsidiary
February 26, 2018
New Analyst Report
February 15, 2018
SUDA Completes Acquisition Of Anti-Cancer Agent
January 23, 2018